Des-Arg9-bradykinin causes kinin B1 receptor mediated endothelium-independent contractions in endotoxin-treated porcine coronary arteries

Medicine & Life Sciences

• (2-(4-(4-isopropoxybenzyl)-phenylamino) imidazoline) 51%
• 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt 41%
• 2-((3-(1,3-benzodioxol-5-yl)-3-(((6-methoxy-2-naphthyl)sulfonyl)amino)propanoyl)amino)-3-(4-((2,6-dimethylpiperidinyl)methyl)phenyl)-N-isopropyl-N-methylpropanamide 51%
• 3,17-diacetoxyestra-1,3,5(10)-trien-2-carboxylic acid 53%
• 4-amylcinnamoylanthranilic acid 51%
• 6-isopropoxy-9-oxoxanthene-2-carboxylic acid 44%
• AL 8810 52%
• Bradykinin 86%
• Celecoxib 32%
• Coronary Vessels 62%
• Cyclooxygenase 1 66%
• Cyclooxygenase 2 53%
• Cyclooxygenase 2 Inhibitors 30%
• Cyclooxygenase Inhibitors 61%
• Dinoprost 31%
• Endothelial Cells 18%
• Endothelium 68%
• endotoxin receptor 45%
• Endotoxins 76%
• icatibant 38%
• Indomethacin 25%
• Inflammation 15%
• Kinins 100%
• Lipopolysaccharides 43%
• Messenger RNA 14%
• Polymerase Chain Reaction 15%
• prostaglandin D2 receptor 42%
• prostaglandin F2alpha receptor 41%
• Prostaglandins 72%
• Salicylates 32%
• Swine 60%
• terbogrel 58%
• Thromboxane Receptors 37%
• Thromboxane-A Synthase 38%
• Up-Regulation 18%